References

The Changing Landscape of Atherosclerosis

10.1038/s41586-021-03392-8 · 2021 · External reference

The Changing Landscape of Atherosclerosis

10.1038/s41586-021-03392-8 · 2021 · External reference

Inflammation in Atherosclerosis: Pathophysiology and Mechanisms

10.1038/s41419-024-07166-8 · 2024 · External reference

Inflammation in Atherosclerosis: Pathophysiology and Mechanisms

10.1038/s41419-024-07166-8 · 2024 · External reference

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

10.1124/pharmrev.120.000096 · 2021 · External reference

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

10.1124/pharmrev.120.000096 · 2021 · External reference

Macrophage Polarization and Metabolism in Atherosclerosis

10.1038/s41419-023-06206-z · 2023 · External reference

Macrophage Polarization and Metabolism in Atherosclerosis

10.1038/s41419-023-06206-z · 2023 · External reference

Foam Cells in Atherosclerosis

10.1016/j.cca.2013.06.006 · 2013 · External reference

Foam Cells in Atherosclerosis

10.1016/j.cca.2013.06.006 · 2013 · External reference

Apolipoprotein B-Containing Lipoproteins in Atherogenesis

10.1038/s41569-024-01111-0 · 2025 · External reference

Apolipoprotein B-Containing Lipoproteins in Atherogenesis

10.1038/s41569-024-01111-0 · 2025 · External reference

NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals

10.1038/nature08938 · 2010 · External reference

NLRP3 Inflammasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals

10.1038/nature08938 · 2010 · External reference

Cholesterol Crystals in the Pathogenesis of Atherosclerosis

10.1038/s41569-024-01100-3 · 2025 · External reference

Cholesterol Crystals in the Pathogenesis of Atherosclerosis

10.1038/s41569-024-01100-3 · 2025 · External reference

Inflammasomes and Atherosclerosis: A Mixed Picture

10.1161/circresaha.123.321637 · 2023 · External reference

Inflammasomes and Atherosclerosis: A Mixed Picture

10.1161/circresaha.123.321637 · 2023 · External reference

Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis

10.1161/circresaha.116.309326 · 2017 · External reference

Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis

10.1161/circresaha.116.309326 · 2017 · External reference

Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances

10.1124/pharmrev.124.001060 · 2024 · External reference

Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances

10.1124/pharmrev.124.001060 · 2024 · External reference

Amino Acid-Based Biomaterials for Modulation of Cell Behaviors: From Mechanisms to Biomedical Applications

10.1039/d5cs01504a · 2026 · External reference

Amino Acid-Based Biomaterials for Modulation of Cell Behaviors: From Mechanisms to Biomedical Applications

10.1039/d5cs01504a · 2026 · External reference

Immunologically Effective Chiral Polymers to Potentiate Anti-Cancer Immune Responses

10.1021/polymscitech.5c00110 · 2025 · External reference

Immunologically Effective Chiral Polymers to Potentiate Anti-Cancer Immune Responses

10.1021/polymscitech.5c00110 · 2025 · External reference

Unimolecular Chiral Poly(amino acid)s as Adjuvants of Nanovaccines for Augmented Cancer Immunotherapy

10.1016/j.cclet.2025.111477 · 2025 · External reference

Unimolecular Chiral Poly(amino acid)s as Adjuvants of Nanovaccines for Augmented Cancer Immunotherapy

10.1016/j.cclet.2025.111477 · 2025 · External reference

Cell Membrane-Derived Nanomaterials for Biomedical Applications

10.1016/j.biomaterials.2017.02.041 · 2017 · External reference

Cell Membrane-Derived Nanomaterials for Biomedical Applications

10.1016/j.biomaterials.2017.02.041 · 2017 · External reference

Biomimetic Nanodrug Targets Inflammation and Suppresses YAP/TAZ to Ameliorate Atherosclerosis

10.1016/j.biomaterials.2024.122505 · 2024 · External reference

Biomimetic Nanodrug Targets Inflammation and Suppresses YAP/TAZ to Ameliorate Atherosclerosis

10.1016/j.biomaterials.2024.122505 · 2024 · External reference

Biomimetic Nanoparticles to Enhance the Reverse Cholesterol Transport for Selectively Inhibiting Development into Foam Cell in Atherosclerosis

10.1186/s12951-023-02040-9 · 2023 · External reference

Biomimetic Nanoparticles to Enhance the Reverse Cholesterol Transport for Selectively Inhibiting Development into Foam Cell in Atherosclerosis

10.1186/s12951-023-02040-9 · 2023 · External reference

Synthetic Polymers for Drug, Gene, and Vaccine Delivery

10.1021/polymscitech.5c00010 · 2025 · External reference

Synthetic Polymers for Drug, Gene, and Vaccine Delivery

10.1021/polymscitech.5c00010 · 2025 · External reference

Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis

10.1021/acsami.4c11370 · 2024 · External reference

Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis

10.1021/acsami.4c11370 · 2024 · External reference

Near Infrared Light-Activatable Platelet-Mimicking NIR-II NO Nano-Prodrug for Precise Atherosclerosis Theranostics

10.1002/advs.202304994 · 2024 · External reference

Near Infrared Light-Activatable Platelet-Mimicking NIR-II NO Nano-Prodrug for Precise Atherosclerosis Theranostics

10.1002/advs.202304994 · 2024 · External reference

US-Triggered On-Demand NO-Releasing Biomimetic Nanoparticle to Remodel Endothelial Microenvironment for Enhancing Atherosclerosis-Specific Gas Therapy

10.1016/j.mtbio.2025.102253 · 2025 · External reference

US-Triggered On-Demand NO-Releasing Biomimetic Nanoparticle to Remodel Endothelial Microenvironment for Enhancing Atherosclerosis-Specific Gas Therapy

10.1016/j.mtbio.2025.102253 · 2025 · External reference

Nitric Oxide-Delivering High-Density Lipoprotein-like Nanoparticles as a Biomimetic Nanotherapy for Vascular Diseases

10.1021/acsami.7b18525 · 2018 · External reference

Nitric Oxide-Delivering High-Density Lipoprotein-like Nanoparticles as a Biomimetic Nanotherapy for Vascular Diseases

10.1021/acsami.7b18525 · 2018 · External reference

Membraneless Compartmentalization Facilitates Enzymatic Cascade Reactions and Reduces Substrate Inhibition

10.1021/acsami.8b07573 · 2018 · External reference

Membraneless Compartmentalization Facilitates Enzymatic Cascade Reactions and Reduces Substrate Inhibition

10.1021/acsami.8b07573 · 2018 · External reference

Coacervates as Enzymatic Microreactors

10.1039/d4cs01203h · 2025 · External reference

Coacervates as Enzymatic Microreactors

10.1039/d4cs01203h · 2025 · External reference

Programmed Spatial Organization of Biomacromolecules into Discrete, Coacervate-Based Protocells

10.1038/s41467-020-20124-0 · 2020 · External reference

Programmed Spatial Organization of Biomacromolecules into Discrete, Coacervate-Based Protocells

10.1038/s41467-020-20124-0 · 2020 · External reference

Construction of Coacervate-in-Coacervate Multi-Compartment Protocells for Spatial Organization of Enzymatic Reactions

10.1039/d0sc03849k · 2020 · External reference

Construction of Coacervate-in-Coacervate Multi-Compartment Protocells for Spatial Organization of Enzymatic Reactions

10.1039/d0sc03849k · 2020 · External reference

Coacervate Vesicles Assembled by Liquid–Liquid Phase Separation Improve Delivery of Biopharmaceuticals

10.1038/s41557-024-01705-8 · 2025 · External reference

Coacervate Vesicles Assembled by Liquid–Liquid Phase Separation Improve Delivery of Biopharmaceuticals

10.1038/s41557-024-01705-8 · 2025 · External reference

Enzyme-Mediated Nitric Oxide Production in Vasoactive Erythrocyte Membrane-Enclosed Coacervate Protocells

10.1038/s41557-020-00585-y · 2020 · External reference

Enzyme-Mediated Nitric Oxide Production in Vasoactive Erythrocyte Membrane-Enclosed Coacervate Protocells

10.1038/s41557-020-00585-y · 2020 · External reference

Tuning Interfacial Fluidity and Colloidal Stability of Membranized Coacervate Protocells

10.1038/s42004-024-01193-4 · 2024 · External reference

Tuning Interfacial Fluidity and Colloidal Stability of Membranized Coacervate Protocells

10.1038/s42004-024-01193-4 · 2024 · External reference

Engineering the Coacervate Microdroplet Interface via Polyelectrolyte and Surfactant Complexation

10.1021/acsami.3c00727 · 2023 · External reference

Engineering the Coacervate Microdroplet Interface via Polyelectrolyte and Surfactant Complexation

10.1021/acsami.3c00727 · 2023 · External reference

Crystal Structure of the Inclusion Complex of Cholesterol in β-Cyclodextrin and Molecular Dynamics Studies

10.3762/bjoc.14.69 · 2018 · External reference

Crystal Structure of the Inclusion Complex of Cholesterol in β-Cyclodextrin and Molecular Dynamics Studies

10.3762/bjoc.14.69 · 2018 · External reference

Sulfobutylether-β-Cyclodextrin

10.1016/j.ijpharm.2020.119396 · 2020 · External reference

Sulfobutylether-β-Cyclodextrin

10.1016/j.ijpharm.2020.119396 · 2020 · External reference

Sulfobutylether-β-Cyclodextrin: A Functional Biopolymer for Drug Delivery Applications

10.1016/j.carbpol.2022.120347 · 2023 · External reference

Sulfobutylether-β-Cyclodextrin: A Functional Biopolymer for Drug Delivery Applications

10.1016/j.carbpol.2022.120347 · 2023 · External reference

Catalytic Peptide-Based Coacervates for Enhanced Function through Structural Organization and Substrate Specificity

10.1038/s41467-024-53699-z · 2024 · External reference

Catalytic Peptide-Based Coacervates for Enhanced Function through Structural Organization and Substrate Specificity

10.1038/s41467-024-53699-z · 2024 · External reference

Detection and Imaging of Nitric Oxide with Novel Fluorescent Indicators: Diaminofluoresceins

10.1021/ac9801723 · 1998 · External reference

Detection and Imaging of Nitric Oxide with Novel Fluorescent Indicators: Diaminofluoresceins

10.1021/ac9801723 · 1998 · External reference

Fluorescent Indicators for Imaging Nitric Oxide Production

10.1002/(sici)1521-3773(19991102)38:21<3209::aid-anie3209>3.0.co;2-6 · 1999 · External reference

Fluorescent Indicators for Imaging Nitric Oxide Production

10.1002/(sici)1521-3773(19991102)38:21<3209::aid-anie3209>3.0.co;2-6 · 1999 · External reference

Enzyme-Active Liquid Coacervate Microdroplets as Artificial Membraneless Organelles for Intracellular ROS Scavenging

10.1039/d2bm00713d · 2022 · External reference

Enzyme-Active Liquid Coacervate Microdroplets as Artificial Membraneless Organelles for Intracellular ROS Scavenging

10.1039/d2bm00713d · 2022 · External reference

Membranized Coacervate Microdroplets: From Versatile Protocell Models to Cytomimetic Materials

10.1021/acs.accounts.2c00696 · 2023 · External reference

Membranized Coacervate Microdroplets: From Versatile Protocell Models to Cytomimetic Materials

10.1021/acs.accounts.2c00696 · 2023 · External reference

Toward Rational Design of High-Efficiency Enzyme Cascades

10.1021/acscatal.7b01766 · 2017 · External reference

Toward Rational Design of High-Efficiency Enzyme Cascades

10.1021/acscatal.7b01766 · 2017 · External reference

Thermo-Sensitive Poly(amino acid) Hydrogel Mediates Cytoprotection through an Antioxidant Mechanism

10.1016/j.cclet.2024.110433 · 2025 · External reference

Thermo-Sensitive Poly(amino acid) Hydrogel Mediates Cytoprotection through an Antioxidant Mechanism

10.1016/j.cclet.2024.110433 · 2025 · External reference

Development of a Fluorescent Indicator for Nitric Oxide Based on the Fluorescein Chromophore

10.1248/cpb.46.373 · 1998 · External reference

Development of a Fluorescent Indicator for Nitric Oxide Based on the Fluorescein Chromophore

10.1248/cpb.46.373 · 1998 · External reference

Biomimetic Ginsenoside Rb1 and Probucol Co-Assembled Nanoparticles for Targeted Atherosclerosis Therapy via Inhibition of Oxidative Stress, Inflammation, and Lipid Deposition

10.1021/acsnano.5c02492 · 2025 · External reference

Biomimetic Ginsenoside Rb1 and Probucol Co-Assembled Nanoparticles for Targeted Atherosclerosis Therapy via Inhibition of Oxidative Stress, Inflammation, and Lipid Deposition

10.1021/acsnano.5c02492 · 2025 · External reference

Cell Autonomous Functions of CD47 in Regulating Cellular Plasticity and Metabolic Plasticity

10.1038/s41418-024-01347-w · 2024 · External reference

Cell Autonomous Functions of CD47 in Regulating Cellular Plasticity and Metabolic Plasticity

10.1038/s41418-024-01347-w · 2024 · External reference

Targeting Endothelial Vascular Cell Adhesion Molecule-1 in Atherosclerosis: Drug Discovery and Development of Vascular Cell Adhesion Molecule-1-Directed Novel Therapeutics

10.1093/cvr/cvad130 · 2023 · External reference

Targeting Endothelial Vascular Cell Adhesion Molecule-1 in Atherosclerosis: Drug Discovery and Development of Vascular Cell Adhesion Molecule-1-Directed Novel Therapeutics

10.1093/cvr/cvad130 · 2023 · External reference

Macrophage-Targeting Antisenescence Nanomedicine Enables In Situ NO Induction for Gaseous and Antioxidative Atherosclerosis Intervention

10.1016/j.bioactmat.2025.02.025 · 2025 · External reference

Macrophage-Targeting Antisenescence Nanomedicine Enables In Situ NO Induction for Gaseous and Antioxidative Atherosclerosis Intervention

10.1016/j.bioactmat.2025.02.025 · 2025 · External reference

Nitric Oxide Generation and Endothelial Progenitor Cells Recruitment for Improving Hemocompatibility and Accelerating Endothelialization of Tissue Engineering Heart Valve

10.1002/adfm.202211267 · 2023 · External reference

Nitric Oxide Generation and Endothelial Progenitor Cells Recruitment for Improving Hemocompatibility and Accelerating Endothelialization of Tissue Engineering Heart Valve

10.1002/adfm.202211267 · 2023 · External reference

Semiconducting Polymer Nanoparticles Enable Light-Controlled Bidirectional Modulation of Nitric Oxide in Endothelial Cells

10.1002/advs.202522894 · 2026 · External reference

Semiconducting Polymer Nanoparticles Enable Light-Controlled Bidirectional Modulation of Nitric Oxide in Endothelial Cells

10.1002/advs.202522894 · 2026 · External reference

Targeting Inflammation in Atherosclerosis—From Experimental Insights to the Clinic

10.1038/s41573-021-00198-1 · 2021 · External reference

Targeting Inflammation in Atherosclerosis—From Experimental Insights to the Clinic

10.1038/s41573-021-00198-1 · 2021 · External reference

Inflammation and Atherosclerosis: Signaling Pathways and Therapeutic Intervention

10.1038/s41392-022-00955-7 · 2022 · External reference

Inflammation and Atherosclerosis: Signaling Pathways and Therapeutic Intervention

10.1038/s41392-022-00955-7 · 2022 · External reference

2′-5′ Oligoadenylate Synthetase-like 1 (OASL1) Protects against Atherosclerosis by Maintaining Endothelial Nitric Oxide Synthase mRNA Stability

10.1038/s41467-022-34433-z · 2022 · External reference

2′-5′ Oligoadenylate Synthetase-like 1 (OASL1) Protects against Atherosclerosis by Maintaining Endothelial Nitric Oxide Synthase mRNA Stability

10.1038/s41467-022-34433-z · 2022 · External reference

Vascular Smooth Muscle Cells in Atherosclerosis

10.1161/circresaha.115.306361 · 2019 · External reference

Vascular Smooth Muscle Cells in Atherosclerosis

10.1161/circresaha.115.306361 · 2019 · External reference

Matrix Metalloproteinases in Coronary Artery Disease and Myocardial Infarction

10.1007/s00395-023-00987-2 · 2023 · External reference

Matrix Metalloproteinases in Coronary Artery Disease and Myocardial Infarction

10.1007/s00395-023-00987-2 · 2023 · External reference

The Interplay of Collagen, Macrophages, and Microcalcification in Atherosclerotic Plaque Cap Rupture Mechanics

10.1007/s00395-024-01033-5 · 2024 · External reference

The Interplay of Collagen, Macrophages, and Microcalcification in Atherosclerotic Plaque Cap Rupture Mechanics

10.1007/s00395-024-01033-5 · 2024 · External reference

Nitric Oxide Decreases Cytokine-Induced Endothelial Activation: Nitric Oxide Selectively Reduces Endothelial Expression of Adhesion Molecules and Proinflammatory Cytokines

10.1172/jci118074 · 1995 · External reference

Nitric Oxide Decreases Cytokine-Induced Endothelial Activation: Nitric Oxide Selectively Reduces Endothelial Expression of Adhesion Molecules and Proinflammatory Cytokines

10.1172/jci118074 · 1995 · External reference